Polaryx Therapeutics, Inc. (PLYX)

Polaryx Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Polaryx Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-8.21	-30.36	-3.78
Share-Based Compensation	-	2.4	3.24
Other Operating Activities	4.9	25.38	0.37
Operating Cash Flow	-3.31	-2.57	-0.17
Share Issuance / Repurchase	-	7.32	-
Debt Issued / Paid	-	-0.13	0.13
Financing Cash Flow	6.33	7.19	0.13
Net Cash Flow	3.01	4.62	-0.05
Free Cash Flow	-3.31	-2.57	-0.17

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).